Movement Alert｜METIS TECHBIO-P Falls 6.34% in Regular Trading, Biotechnology Sector Under Pressure

Market Focus10-13

On October 13, METIS TECHBIO-P fell 6.34% in regular trading, trading at HK$12.13 with turnover of HK$20.32 million. The decline was driven by continued weakness across the Hong Kong biotechnology sector, with AI-driven drug discovery names broadly under pressure.

The sector has been systemically correcting after a strong prior rally as shifting US interest rate expectations continue to weigh on high-duration, zero-revenue biotech companies. While the company's interim results showed revenue of RMB154 million, up 13,399% year-over-year, and adjusted net loss narrowing 56.4% to RMB51 million, the near-term sector-wide correction has dominated price action.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment